After testing the effects of Nutlin-3 on NPC and nasopharyngeal epithelial (NPE) cell lines, it has been revealed that the drug inhibits the p53-MDM2 interaction more strongly in NPC cells (C666-1) than in NPE cells (NP69 and NP460) [124]. Here, TP53 is linked to nasopharyngeal carcinoma.